Jason Amello - 21 Sep 2022 Form 3 Insider Report for Candel Therapeutics, Inc. (CADL)

Role: Chief Financial Officer
Signature: /s/ Jason A. Amello
Issuer symbol: CADL
Transactions as of: 21 Sep 2022
Net transactions value: $0
Form type: 3
Filing time: 23 Sep 2022, 16:10:10 UTC
Previous filing: 19 Jan 2022
Next filing: 30 Nov 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit 24 - Power of Attorney No securities are beneficially owned.